in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Fine Chemicals: A Promising Outlook
2:21 PM MDT | October 17, 2011 | —DEEPTI RAMESH
The outlook for contract manufacturers looks promising despite cost pressures and increased competition, pharmaceutical ingredient manufacturers say. Active pharma ingredient (API) and pharma intermediate producers plan further expansion of their activities, including investments in new geographies. Regulatory bodies, meanwhile, are tightening their scrutiny of the sector. Hardy: Plans to establish a manufacturing presence in Asia and U.S. in 2012. The $40-billion/year global API market is expected to grow 4%-5%/year in volume terms and 0%-1%/year in value terms...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee